Skip to main content
Top
Published in: Acta Diabetologica 3/2013

01-06-2013 | Original Article

Influence of heart rate at rest for predicting the metabolic syndrome in older Chinese adults

Authors: Bríain ó Hartaigh, Chao Qiang Jiang, Jos A. Bosch, Wei Sen Zhang, Kar Keung Cheng, Tai Hing Lam, G. Neil Thomas

Published in: Acta Diabetologica | Issue 3/2013

Login to get access

Abstract

The aim of this study was to examine the relationship between seated resting heart rate and the metabolic syndrome (MetS) among older residents of Guangzhou, South China. A total of 30,519 older participants (≥50 years) from the Guangzhou Biobank Cohort Study were stratified into quartiles based on seated resting heart rate. The associations between each quartile and the MetS were assessed using multivariable logistic regression. A total of 6,907 (22.8 %) individuals were diagnosed as having the MetS, which was significantly associated with increasing heart rate quartiles (P < 0.001). Participants in the uppermost quartile (mean resting heart rate 91 ± 8 beats/min) of this cardiovascular proxy had an almost twofold increased adjusted risk (odds ratio (95 % CI) = 1.94 (1.79, 2.11), P < 0.001) for the MetS, as compared to those in the lowest quartile (mean resting heart rate, 63 ± 4 beats/min). Heart rate, which is an inexpensive and simple clinical measure, was independently associated with the MetS in older Chinese adults. We hope these observations will spur further studies to examine the usefulness of resting heart rate as a means of risk stratification in such populations, for which targeted interventions should be implemented.
Literature
1.
go back to reference Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome–a new worldwide definition. Lancet 366:1059–1062PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome–a new worldwide definition. Lancet 366:1059–1062PubMedCrossRef
2.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef
3.
go back to reference Kylin E (1923) Studien ueber das hypertonie-hyperglykämie-hyperurikä-miesyndrom. Zentralblatt fuer Innere Medizin 44:105–127 Kylin E (1923) Studien ueber das hypertonie-hyperglykämie-hyperurikä-miesyndrom. Zentralblatt fuer Innere Medizin 44:105–127
4.
go back to reference Ford ES (2004) The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173:309–314PubMedCrossRef Ford ES (2004) The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173:309–314PubMedCrossRef
5.
go back to reference Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S (1997) Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 30:1267–1273PubMedCrossRef Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S (1997) Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 30:1267–1273PubMedCrossRef
6.
go back to reference Palatini P, Julius S (1999) The physiological determinants and risk correlations of elevated heart rate. Am J Hypertens 12:3S–8SPubMedCrossRef Palatini P, Julius S (1999) The physiological determinants and risk correlations of elevated heart rate. Am J Hypertens 12:3S–8SPubMedCrossRef
7.
go back to reference Rogowski O, Steinvil A, Berliner S, Cohen M, Saar N, Ben-Bassat OK et al (2009) Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol 8:55PubMedCrossRef Rogowski O, Steinvil A, Berliner S, Cohen M, Saar N, Ben-Bassat OK et al (2009) Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol 8:55PubMedCrossRef
8.
go back to reference Panzer C, Lauer MS, Brieke A, Blackstone E, Hoogwerf B (2002) Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes 51:803–807PubMedCrossRef Panzer C, Lauer MS, Brieke A, Blackstone E, Hoogwerf B (2002) Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes 51:803–807PubMedCrossRef
9.
go back to reference Gillum RF (1988) The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J 116:163–174PubMedCrossRef Gillum RF (1988) The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J 116:163–174PubMedCrossRef
10.
go back to reference Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM et al (1980) Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112:736–749PubMed Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM et al (1980) Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112:736–749PubMed
11.
go back to reference Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 113:1489–1494PubMedCrossRef Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 113:1489–1494PubMedCrossRef
12.
go back to reference Gillum RF, Makuc DM, Feldman JJ (1991) Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 121:172–177PubMedCrossRef Gillum RF, Makuc DM, Feldman JJ (1991) Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 121:172–177PubMedCrossRef
13.
go back to reference Gillman MW, Kannel WB, Belanger A, D’Agostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 125:1148–1154PubMedCrossRef Gillman MW, Kannel WB, Belanger A, D’Agostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 125:1148–1154PubMedCrossRef
14.
go back to reference Aronow WS, Ahn C, Mercando AD, Epstein S (1996) Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 78:1175–1176PubMed Aronow WS, Ahn C, Mercando AD, Epstein S (1996) Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 78:1175–1176PubMed
15.
go back to reference Palatini P, Casiglia E, Julius S, Pessina AC (1999) High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 159:585–592PubMedCrossRef Palatini P, Casiglia E, Julius S, Pessina AC (1999) High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 159:585–592PubMedCrossRef
16.
go back to reference Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM (2006) High heart rate: a cardiovascular risk factor? Eur Heart J 27:2387–2393PubMedCrossRef Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM (2006) High heart rate: a cardiovascular risk factor? Eur Heart J 27:2387–2393PubMedCrossRef
17.
18.
go back to reference Thomas GN, Schooling CM, McGhee SM, Ho SY, Cheung BM, Wat NM et al (2007) Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor study. Clin Endocrinol (Oxf) 66:666–671CrossRef Thomas GN, Schooling CM, McGhee SM, Ho SY, Cheung BM, Wat NM et al (2007) Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor study. Clin Endocrinol (Oxf) 66:666–671CrossRef
19.
go back to reference O’Hartaigh B, Jiang CQ, Bosch JA, Zhang WS, Cheng KK, Lam TH et al (2011) Independent and combined associations of abdominal obesity and seated resting heart rate with type 2 diabetes among older Chinese: the Guangzhou Biobank Cohort study. Diabetes Metab Res Rev 27:298–306CrossRef O’Hartaigh B, Jiang CQ, Bosch JA, Zhang WS, Cheng KK, Lam TH et al (2011) Independent and combined associations of abdominal obesity and seated resting heart rate with type 2 diabetes among older Chinese: the Guangzhou Biobank Cohort study. Diabetes Metab Res Rev 27:298–306CrossRef
20.
go back to reference O’Hartaigh B, Jiang CQ, Thomas GN, Tsvetanov KA, Bosch JA, Cheng KK et al (2011) Usefulness of physical fitness and the metabolic syndrome to predict vascular disease risk in older Chinese (from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort [GBCS-CVD]). Am J Cardiol 108:845–850PubMedCrossRef O’Hartaigh B, Jiang CQ, Thomas GN, Tsvetanov KA, Bosch JA, Cheng KK et al (2011) Usefulness of physical fitness and the metabolic syndrome to predict vascular disease risk in older Chinese (from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort [GBCS-CVD]). Am J Cardiol 108:845–850PubMedCrossRef
21.
go back to reference Thomas GN, Jiang CQ, Lao XQ, McGhee SM, Zhang WS, Schooling CM et al (2006) Snoring and vascular risk factors and disease in a low-risk Chinese population: the Guangzhou Biobank Cohort study. Sleep 29:896–900PubMed Thomas GN, Jiang CQ, Lao XQ, McGhee SM, Zhang WS, Schooling CM et al (2006) Snoring and vascular risk factors and disease in a low-risk Chinese population: the Guangzhou Biobank Cohort study. Sleep 29:896–900PubMed
22.
go back to reference Jiang C, Thomas GN, Lam TH, Schooling CM, Zhang W, Lao X et al (2006) Cohort profile: the Guangzhou Biobank Cohort study, a Guangzhou-Hong Kong-Birmingham collaboration. Int J Epidemiol 35:844–852PubMedCrossRef Jiang C, Thomas GN, Lam TH, Schooling CM, Zhang W, Lao X et al (2006) Cohort profile: the Guangzhou Biobank Cohort study, a Guangzhou-Hong Kong-Birmingham collaboration. Int J Epidemiol 35:844–852PubMedCrossRef
23.
go back to reference Deng HB, Macfarlane DJ, Thomas GN, Lao XQ, Jiang CQ, Cheng KK et al (2008) Reliability and validity of the IPAQ-Chinese: the Guangzhou Biobank Cohort study. Med Sci Sports Exerc 40:303–307PubMedCrossRef Deng HB, Macfarlane DJ, Thomas GN, Lao XQ, Jiang CQ, Cheng KK et al (2008) Reliability and validity of the IPAQ-Chinese: the Guangzhou Biobank Cohort study. Med Sci Sports Exerc 40:303–307PubMedCrossRef
24.
go back to reference Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef
25.
go back to reference Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575–581PubMedCrossRef Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575–581PubMedCrossRef
26.
go back to reference Singh BN (2003) Increased heart rate as a risk factor for cardiovascular disease. Eur Heart J Suppl 5:G3–G9CrossRef Singh BN (2003) Increased heart rate as a risk factor for cardiovascular disease. Eur Heart J Suppl 5:G3–G9CrossRef
27.
go back to reference Martin LJ, Comuzzie AG, Sonnenberg GE, Myklebust J, James R, Marks J et al (2004) Major quantitative trait locus for resting heart rate maps to a region on chromosome 4. Hypertension 43:1146–1151PubMedCrossRef Martin LJ, Comuzzie AG, Sonnenberg GE, Myklebust J, James R, Marks J et al (2004) Major quantitative trait locus for resting heart rate maps to a region on chromosome 4. Hypertension 43:1146–1151PubMedCrossRef
28.
go back to reference Gianiorio FE, Casu M, Patrone V, Egan CG, Murialdo G (2011) Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes. Acta Diabetol 48:283–290PubMedCrossRef Gianiorio FE, Casu M, Patrone V, Egan CG, Murialdo G (2011) Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes. Acta Diabetol 48:283–290PubMedCrossRef
29.
go back to reference Nerla R, Pitocco D, Zaccardi F, Scalone G, Coviello I, Mollo R et al (2011) Effect of pioglitazone on systemic inflammation is independent of metabolic control and cardiac autonomic function in patients with type 2 diabetes. Acta Diabetol 47:117–122CrossRef Nerla R, Pitocco D, Zaccardi F, Scalone G, Coviello I, Mollo R et al (2011) Effect of pioglitazone on systemic inflammation is independent of metabolic control and cardiac autonomic function in patients with type 2 diabetes. Acta Diabetol 47:117–122CrossRef
30.
go back to reference Poanta L, Porojan M, Dumitrascu DL (2011) Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol 48:191–196PubMedCrossRef Poanta L, Porojan M, Dumitrascu DL (2011) Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol 48:191–196PubMedCrossRef
31.
go back to reference Julius S, Valentini M, Palatini P (2000) Overweight and hypertension: a 2-way street? Hypertension 35:807–813PubMedCrossRef Julius S, Valentini M, Palatini P (2000) Overweight and hypertension: a 2-way street? Hypertension 35:807–813PubMedCrossRef
32.
go back to reference Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG (2003) Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism 52:1056–1061PubMedCrossRef Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG (2003) Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism 52:1056–1061PubMedCrossRef
33.
go back to reference Narkiewicz K, Kato M, Phillips BG, Pesek CA, Choe I, Winnicki M et al (2001) Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 19:1089–1094PubMedCrossRef Narkiewicz K, Kato M, Phillips BG, Pesek CA, Choe I, Winnicki M et al (2001) Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 19:1089–1094PubMedCrossRef
34.
go back to reference Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L et al (2004) Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256:128–136PubMedCrossRef Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L et al (2004) Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256:128–136PubMedCrossRef
35.
go back to reference Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K et al (1999) Leptin is associated with increased risk of myocardial infarction. J Intern Med 246:409–418PubMedCrossRef Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K et al (1999) Leptin is associated with increased risk of myocardial infarction. J Intern Med 246:409–418PubMedCrossRef
36.
go back to reference Hodis J, Gaier N, Farghali H (2009) Nitric oxide in patients with obesity and metabolic syndrome. Cas Lek Cesk 148:34–38PubMed Hodis J, Gaier N, Farghali H (2009) Nitric oxide in patients with obesity and metabolic syndrome. Cas Lek Cesk 148:34–38PubMed
37.
go back to reference Nisoli E, Clementi E, Carruba MO, Moncada S (2007) Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 100:795–806PubMedCrossRef Nisoli E, Clementi E, Carruba MO, Moncada S (2007) Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 100:795–806PubMedCrossRef
38.
go back to reference Ren J, Pulakat L, Whaley-Connell A, Sowers JR (2010) Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berl) 88:993–1001CrossRef Ren J, Pulakat L, Whaley-Connell A, Sowers JR (2010) Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berl) 88:993–1001CrossRef
39.
go back to reference Chowdhary S, Vaile JC, Fletcher J, Ross HF, Coote JH, Townend JN (2000) Nitric oxide and cardiac autonomic control in humans. Hypertension 36:264–269PubMedCrossRef Chowdhary S, Vaile JC, Fletcher J, Ross HF, Coote JH, Townend JN (2000) Nitric oxide and cardiac autonomic control in humans. Hypertension 36:264–269PubMedCrossRef
40.
go back to reference Chowdhary S, Ng GA, Nuttall SL, Coote JH, Ross HF, Townend JN (2002) Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci (Lond) 102:397–402CrossRef Chowdhary S, Ng GA, Nuttall SL, Coote JH, Ross HF, Townend JN (2002) Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci (Lond) 102:397–402CrossRef
41.
go back to reference Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X et al (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: international collaborative study of cardiovascular disease in Asia (InterASIA). Diabetologia 46:1190–1198PubMedCrossRef Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X et al (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: international collaborative study of cardiovascular disease in Asia (InterASIA). Diabetologia 46:1190–1198PubMedCrossRef
42.
go back to reference Gu DF, Jiang H, Wu XG, Reynolds K, Gan WQ, Liu DH et al (2003) Prevalence, awareness, treatment and control of hypertension in Chinese adults. Zhonghua Yu Fang Yi Xue Za Zhi 37:84–89PubMed Gu DF, Jiang H, Wu XG, Reynolds K, Gan WQ, Liu DH et al (2003) Prevalence, awareness, treatment and control of hypertension in Chinese adults. Zhonghua Yu Fang Yi Xue Za Zhi 37:84–89PubMed
Metadata
Title
Influence of heart rate at rest for predicting the metabolic syndrome in older Chinese adults
Authors
Bríain ó Hartaigh
Chao Qiang Jiang
Jos A. Bosch
Wei Sen Zhang
Kar Keung Cheng
Tai Hing Lam
G. Neil Thomas
Publication date
01-06-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-012-0396-z

Other articles of this Issue 3/2013

Acta Diabetologica 3/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.